Graeme Sloan – Managing Director – Kali Metals (ASX:KM1) is a portfolio of assets that represents one of the largest and most prospective exploration packages across Australia’s world leading hard-rock lithium fields.
Copyright 2024 – Finance News Network
Source: Finance News Network
17 May 2021 - Melbana Energy Limited (ASX:MAY) Executive Chairman Andrew Purcell provides an update on the company's key Cuban onshore oil project, including preparation for its two exploration well program scheduled for Q3 2021 and its sale of WA-488-P permit (containing the Beehive Prospect) to a wholly owned Australian subsidiary of the US company EOG Resources, Inc (NYSE:EOG).
Read More21 Oct 2019 - PPK Group Limited (ASX:PPK) Executive Chairman, Robin Levinson talks about FY19 results, strategy, pickup in the company's key market, and the company's joint venture with Deakin University for Boron Nitrate Nanotubes.
Read More27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
Read More09 Sep 2020 - BrainChip Holdings Limited (ASX:BRN) President & CEO Louis DiNardo provides an update on collaboration and partnerships for the company's AI chip, Akida.
Read More24 May 2021 - QEM Limited (ASX:QEM) Managing Director Gavin Loyden provides an update on the company's flagship 100%-owned Julia Creek vanadium and oil shale project in North Queensland.
Read More26 Feb 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO, Stefano Marani provides an update on recent drilling results at the company's Virginia Gas Project in South Africa, what’s planned for this year and the potential to bring forward a second production well.
Read More23 Apr 2021 - Capral Limited (ASX:CAA) Managing Director Tony Dragicevich talks about the company's strong FY20 results despite COVID, its product mix, operating environment and outlook.
Read More18 May 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on clinical trial progression, and discusses recent agreements with WuXi Advanced Therapies and Be The Match BioTherapies.
Read More05 Dec 2019 - Memphasys Limited (ASX:MEM) Executive Chairman, Alison Coutts talks about progress with the company's human assisted reproductive device for the separation of sperm cells in IVF clinics.
Read More16 Nov 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses excess cash in the global economy, inflation, growth and promising investment sectors.
Read More
